StockWatch
·
Biotechnology: Pharmaceutical Preparations
Quarterly ResultAug 3, 2026, 04:28 PM

Ainos Reports $7.05M Six-Month Net Loss; Going Concern Warning

AI Summary

Ainos, Inc. reported a net loss of $7.05 million for the six months ended June 30, 2026, with revenues plummeting to $313 from $110,870 in the prior year. The company disclosed substantial doubt about its ability to continue as a going concern due to recurring net operating losses and an accumulated deficit of $74.57 million. Ainos raised $601,600 in net proceeds from its At-the-Market offering during the first half of 2026 and secured a new loan agreement for $2.81 million.

Key Highlights

  • Net loss for six months ended June 30, 2026, was $7.05 million.
  • Revenues for six months ended June 30, 2026, were $313, down from $110,870 YoY.
  • Net loss per share for six months ended June 30, 2026, was $(1.05).
  • Company disclosed substantial doubt about its ability to continue as a going concern.
  • Accumulated deficit reached $74.57 million as of June 30, 2026.
  • Cash and cash equivalents stood at $1.42 million as of June 30, 2026.
  • Received $601,600 in net proceeds from ATM offering in H1 2026.
  • Secured a new loan agreement for $2.81 million in March 2026.